Douglas Kerr Sells $40.9K of Dyne Therapeutics Inc (DYN) — SEC Form 4, Aug 17, 2026

Open-Market Net Sale · SEC Form 4
−$40,892
10b5-1 Plan

Equity position changed by -0.9%

Reporting Owner
Officer
TXN 2026-08-13 · FILED 2026-08-17
Equity Position 168K sh 169,155 → 167,599
Equity Change -0.9% shares held after vs before
Filing Lag 2 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2026-08-17
Report Date
2026-08-17
Accession No.
0001814189-26-000004
Accepted At
2026-08-17 20:08 UTC
Reporting Owner
Name Relationship
Douglas Kerr CIK 0001814189
Officer
Douglas Kerr at Dyne Therapeutics Inc Full insider history
Bought (12 mo) —
Sold (12 mo) $233,115
More from this insider at Dyne Therapeutics Inc
2026-10-22 Award — View
2026-09-08 Sell -$115,546 View
2026-06-17 Sell -$16,259 View
2026-05-14 Sell -$28,715 View
2026-03-06 Sell -$13,470 View
All filings by this insider at Dyne Therapeutics Inc
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common StockF1F2F3 2026-08-13 S - Sale 10b5-1 1,556 D $26.28 -$40,892 167,599 Direct
Footnotes (3)
F1
Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on February 12, 2026. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person. Show more
F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $26.17 to $26.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4. Show more
F3
Includes 140,001 unvested RSUs. Show more
5%+ Holders · 13D/G 4 filers
Other insiders at Dyne Therapeutics Inc
All Dyne Therapeutics Inc insider activity
GET /v1/forms/4/0001814189-26-000004 API docs
View Original SEC Filing